Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2010

Mar 2, 2010

33869_rns_2010-03-02_484487da-cd75-442b-a962-bfbea81b61bd.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [594 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433

www.biomd.com.au

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 1 page

3 March 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

RIGHTS ISSUE TIMETABLE (AMENDED)

The indicative timetable for the pro-rata non renounceable rights issue, originally announced on 25 February 2010 has been amended as follows:

February 2010 has been amended as follows:
Lodgement of the Offer Document with ASIC and ASX 25 February 2010
Existing Shares trade ex-entitlement to participate in the Offer 4 March 2010
Record Date to determine entitlement to participate in the Offer 11 March 2010
Despatch of Offer Document and Entitlement and Acceptance Forms 17 March 2010
Closing Date for acceptance of applications for New Options 31 March 2010
New Options commence trading on a deferred settlement basis 1 April 2010
Allotment date and despatch date of Holding Statements 12 April 2010
Date of quotation by ASX of New Options on a normal settlement basis 13 April 2010

Yours faithfully

==> picture [78 x 58] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [594 x 42] intentionally omitted <==